International Annual Congress on Cannabis-Based Clinical Pharmacology

International Annual Congress on Cannabis-Based Clinical Pharmacology

Cannabis has become more mainstream due to its application in health and fitness. Cannabis conferences are essential to promote its application and use. The International Annual Congress on Cannabis-Based Clinical Pharmacology is one of such events.

The industry is estimated to generate approximately $20 billion in revenue in the United States alone. The market harbors investors, business owners, and consumers. The non-psychoactive derivative, CBD is being used to promote wellbeing and general health in the form of drinks, CBD-infused edibles, topical solutions, tinctures, vape juices, and bath bombs.

These products are so diverse that they have been welcomes by athletes, celebrities, as well as corporate retail chains like Rite Aid, GNC Holdings, Walgreens, CVS among others.

It doesn’t matter if you are a business owner or a consumer, as long as you want to meet professionals like you or learn about the many benefits of cannabis, a CBD conference is your best bet.

Conference Details

The International Annual Congress on Cannabis-Based Clinical Pharmacology was slated to hold in May 2020 and it is the third one since inception. It didn’t hold as scheduled due to the outbreak of the COVID-19 virus. A new date for the conference has not yet been set. The event is set to hold in Copenhagen, Denmark, and is co-titled Med-Cannabis 2020.

The conference is meant to address issues that surround cannabis-based medicine. Cannabis was barely legal for use decades ago but now, patient and strong demand from members of the public has made it possible for the compound to be used for medical purposes in many countries. The demands have also made it possible for the availability of clinical research to show how it can be used to treat chronic pain in patients.

Also, the conference aims to bring clinicians, researchers, industry professionals, methodologists, national cannabis agencies as well as the European Monitoring Center for Drugs and Drug Addiction. It also aims to discuss the current state of knowledge in the cannabis industry as well as the controversies that have arisen in recent times.

The Advent of Cannabis-Based Pharmacology

Cannabis-based medicines are still new to the industry. Only a few of them have been approved for the treatment of epilepsy and multiple sclerosis. The NHS approved these medicines last year after the body examined the compounds and found that they are indeed useful. Epidolex, one of the medicines, was approved for two types of epilepsy. Dravet syndrome and Lennox-Gaustaut syndrome are quite rare in comparison with other diseases and Epidolex is recommended for its treatment. The second medicine is Sativex which is a spray and it is used to cure the painful muscle spasms that multiple sclerosis patients suffer.

In the not-so-distant past, prescribing medicinal cannabis was legal. However, doctors were still reluctant to prescribe it as there was a grey area when it comes to guidance. During this time, families had to travel to other countries in a bid to find a suitable treatment.

A report showed that around 9,000 people suffer from Lennox-Gaustaut as well as Dravet syndromes. There is a need for more research on such cannabis-based medicines to be able to treat other more common forms of epilepsy.

Why You Should Attend This Meeting

Individuals that attend the cannabis-based medicine conference can learn more about CBD and its uses while also getting the chance to meet and discuss with investors. It is an excellent meeting point for brands who want to show what they have to offer.

Also, the conference will encompass engagement with innovators and thought leaders in the industry. It presents the business owners and present consumers with a long list of benefits such as learning and sharing new information. The main aspect of such conferences is to network. Mixing with experts in the industry can mold future partnerships for the long term. It can also help push the name of the brand to the right audience.

If you choose to attend the International Annual Congress on Cannabis-Based Clinical Pharmacology, be sure to write a list of the questions you need answers to. You can also write some contributions you have to add.